Relafen 750, a advanced preparation of naproxen, presents the intriguing study from our biochemical pharmacy perspective. The mechanism of action, essentially involving blocking of cyclooxygenase enzymes – COX-1 and COX-2 – results to a reduction in prostaglandin production. Within a biochemical context, this drug's effectiveness is strongly as